Epithelial cell growth inhibitors

Details Epithelial cell growth inhibitors Epithelial cell growth inhibitors

2005-09-06

2005-09-06

Nickol, Gary B. (Department: 1642)

Chemistry: analytical and immunological testing

Cancer

C424S009100, C435S007230

Reexamination Certificate

active

06939714

ABSTRACT:
Epithelial cell growth inhibitors differentially express in normal and cancerous epithelial cells. The ECGI proteins and nucleic acid sequence encoding them are useful in the diagnosis and treatment of epithelial cell cancers, for example prostate, ovarian, colon cancer, and the like.

REFERENCES:
patent: WO 96/31625 (1996-10-01), None
patent: WO 98/14577 (1998-04-01), None
patent: WO 99/32625 (1999-07-01), None
Wiersma et al. (Eur J. Immunol. 1991, vol. 21. No. 10, abstract).
Ervin, P. et al., “Identification of a Prostate Analog to the Growth Inhibitor Mammastatin”,Proceedings of the 91st Annual Meeting of the American Association for Cancer Research, p. 251 (Mar. 2000).

Affiliated with

Also associated with

Rating

Epithelial cell growth inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Epithelial cell growth inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epithelial cell growth inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3381478